PIK3CD and breast cancer: These findings are consistent with observations of other groups showing that TRKB promotes survival and metastasis of lung adenocarcinoma, breast cancer, and chondrosarcoma by upregulating PI3K/Akt and JAK/STAT3 signaling [144,145,146].